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Intrahepatic cholangiocarcinoma (ICC) is the second most
common primary liver cancer after hepatocellular carci-
noma (HCC). The risk of ICC is higher in patients with
primary sclerosing cholangitis (PSC). To date, the cellular
and molecular mechanism underlying the pathological
progression of PSC and ICC is poorly understood. IKKa is
part of the IB kinase (IKK) complex, which plays an
important role in regulating inflammation- associated car-
cinogenesis through both NF-B-dependent and indepen-
dent pathways. Here, we show that IKKa mutant mice
developed very serious PSC as early as four weeks of age.
The ALT/AST and bilirubin levels were significantly
increased in the serum of IKKa mutant mice along with
lymphocytic and eosinophilic infiltration into the liver.
Liver inflammation in the IKKa mutant mice, mediated by
macrophages, neutrophils and CD4 T cells, was associated
with the death of cholangiocytes and hepatocytes, and
obstruction of intrahepatic and extrahepatic bile ducts,
which impeded bile flow and ultimately led to biliary fibro-
sis and cirrhosis. Additionally, upon activation of NOTCH
signaling in the liver via hydrodynamic shear, we observed
that NOTCH-induced ICC, with the PSC, developed sig-
nificantly faster in IKKa mutant mice. To identify whether
intrinsic IKKa dysfunction in hepatocytes promotes the
NOTCH-induced ICC in IKKa mutant mice, we gener-
ated IKKa hep KO mice, in which IKKa is conditionally
knocked out in hepatocytes. No biliary disease or liver
injury was observed in these mice. We then established an
accelerated ICC model utilizing hydrodynamic delivery of
NICD and AKT expression vectors. Unexpectedly, ICC
development was remarkably slower in the IKKa hep KO
mice compared to the IKKa floxed control mice, and this
delayed ICC development was associated with reduced
activation or levels of AKT, NOTCH, MAPK/Erk and
c-myc. These data suggest that IKKa may play a protective
role in PSC, while promoting ICC derived from hepato-
cytes. In contrast to ICC, we also established the cMET/b-
catenin-induced HCC model in the IKKa hep KO mice,
which did not reveal any difference in tumor development
between IKKa hep KO and control mice. Taken together,
our findings suggest that IKKa plays complicated and
important roles in PSC and ICC pathological progression.
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